StockData

Femasys Inc (FEMY) stock

FEMYNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 7/3037% below fair value
$1.12−0.16 (-12.50%)

Close on Nov 17, 2026Market cap $9.38MP/E –Yield –

Femasys operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Femasys's operating income for the twelve months ending Jun 30, 2026 was -$17.57M. For fiscal 2025 it was -$17.59M. The highest annual figure on record is -$6.93M in fiscal 2020.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$17.59M–
FY2024Dec 31, 2024-$17.79M–
FY2023Dec 31, 2023-$14.51M–
FY2022Dec 31, 2022-$11.60M–
FY2021Dec 31, 2021-$8.34M–
FY2020Dec 31, 2020-$6.93M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$5.07M–
Q1 FY2026Mar 31, 2026-$4.22M–
Q4 FY2025Dec 31, 2025-$4.62M–
Q3 FY2025Sep 30, 2025-$3.65M–
Q2 FY2025Jun 30, 2025-$3.85M–
Q1 FY2025Mar 31, 2025-$5.46M–
Q4 FY2024Dec 31, 2024-$4.72M–
Q3 FY2024Sep 30, 2024-$5.12M–
Q2 FY2024Jun 30, 2024-$4.48M–
Q1 FY2024Mar 31, 2024-$3.46M–
Q4 FY2023Dec 31, 2023-$4.45M–
Q3 FY2023Sep 30, 2023-$4.08M–
Q2 FY2023Jun 30, 2023-$2.94M–
Q1 FY2023Mar 31, 2023-$3.04M–
Q4 FY2022Dec 31, 2022-$3.00M–
Q3 FY2022Sep 30, 2022-$3.06M–
Q2 FY2022Jun 30, 2022-$2.66M–
Q1 FY2022Mar 31, 2022-$2.88M–
Q4 FY2021Dec 31, 2021-$2.36M–
Q3 FY2021Sep 30, 2021-$2.25M–
Q2 FY2021Jun 30, 2021-$1.90M–
Q1 FY2021Mar 31, 2021-$1.83M–
Q4 FY2020Dec 31, 2020-$1.66M–
Q3 FY2020Sep 30, 2020-$1.56M–
Q2 FY2020Jun 30, 2020-$1.48M–

More Femasys figures

See a number that looks wrong?